PCa occurring in the TZ (which harbors mutations such as an in-frame insertion at X:66765174 or a missense mutation at X:66931247 in the AR gene) may exhibit resistance to drugs such as leuprolide and bicalutamide, which are commonly used to treat PCa. The gene discussed is AR; the disease is posterior cortical atrophy.